NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









SN BioScience

SN BioScience

Private
South KoreaHealthcare & Life Scienceshttps://snbioscience.com

Last Round

Growth Equity

Apr 7, 2026

Est. Valuation

$15.16M

Total Funding Raised

$27.01M

Momentum

Top 10%

of companies Caplight tracks

Company Overview

SN BioScience is a biotechnology company that develops innovative drug delivery systems, particularly nanomedicine and nanoparticle-based therapies for oncology and metabolic diseases.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery, Precision Medicine, Clinical Trials

Business Model

B2B

Customer Profile

Revenue Share, Services & Consulting

AI Layer

Non-AI

Keywords

nano-medicinedrug deliverydrug delivery technanoparticle formulationoncologynanotech drug deliverydrug delivery platformclinical-stage biotechnano-micelle technologydrug formulation servicesbiotech licensingtargeted therapychemotherapy optimizationdrug solubility enhancementcontract research

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

SN BioScience Comparables

Compare SN BioScience with similar companies based on industry and business-model similarity.

SN BioScience comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
OncoNano Medicine
79%
RS Research
74%
Samyang Holdings
71%

SN BioScience Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Growth EquityApr 7, 2026
Series BJul 1, 2020
Series AJan 21, 2019

SN BioScience Investors

Notable investors and investment history

SN BioScience investors
InvestorRounds
Smilegate InvestmentSeries A, Series B
SL InvestmentSeries B
DAYLI PartnersGrowth Equity
Comes InvestmentSeries B
Now IB CapitalGrowth Equity
JL PartnersSeries B
Wonik Investment PartnersSeries B

Market signals

Structured signals derived from secondary market and firmographic data.

  • Apr 7, 2026

    $10.37M round led by Now IB Capital and DAYLI Partners

SN BioScience Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

SN BioScience Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about SN BioScience's valuation, stock price, and market status.

Firmographic Details

HeadquartersSouth Korea
Employee Range6
Year Founded2017
Last FundingApr 7, 2026

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.